Annogen introduces AIM™ service

Identify favorable gene insertions and their expression levels (> 100,000 integrations in parallel)

Annogen introduces a new service to identify gene insertions and asses their expression levels for >100,000 integrations in parallel. Using an adaptation of its proprietary SuRE™ barcoding strategy and previously established protocols, Annogen has now scaled a gene-insertion and expression mapping strategy to unprecedented numbers.

AIM™ applications

  • Genetic engineering T cells, NK cells, B cells
    • E.g. Expression upon T-cell activation or in specific lineage
  • Production lines for stable expression
    • E.g. CHO sites for maximum expression level
  • Production lines for induced expression
    • E.g. HEK293T sites for induced expression of Rep protein
  • Reporter lines for drug screens…
    • E.g. Fluorescence upon inflammation, proliferation, apoptosis, …

Example of AIM™ screen in Jurkat cells

Integrations Heatmap N=310807

Identify loci that are only active upon T-cell activation

Conclusion

300-fold induction upon Jurkat stimulation with lonomycin and PMA

What Distinguishes Annogen In Gene Promoter Design?

What Distinguishes Annogen In Gene Promoter Design?

What makes Annogen’s promoter design stand-out from other providers? A valid question. Let’s put this in historical context. Gene promoter design is nothing new: as early as the 1980’s, researchers began to understand different components within promoters, e.g. TATA...

Technology

 

Solutions

 

Annogen